:: 대한생식의학회 ::

학술행사

국내외 학술행사

HOME > 학술행사 > 국내외 학술행사

한국부인암재단 심포지움 개최
일시	2005년 09월 04일(일) ~ 2005년 01월 01일 (월)
장소	서울대학교병원 임상의학연구소 대강당
주최
참가비
문의처	.
홈페이지
The 1st International Symposium on Papillomavirus - Recent Trends in Research, Development, Clinical Practice and Evaluation Technology (The 5th Annual Symposium of Korea Gynecologic Cancer Foundation) Jointly Organized by Korean Gynecologic Cancer Foundation/ Korea Food & Drug Administration Seoul, Korea, 4 - 5 September, 2005 (SNU Hospital, Clinical Research Institute, Auditorium) Agenda(Draft) Moderator : Dr. Sue N. Park (KFDA) Sep. 04, 2005 (Sunday) 08:30 - 09:00 Registration Jae Weon Kim (KGCF) & Ms. Soon Nam Kim (KFDA) 09:00 - 09:10 Opening Address Prof. Hyo Pyo Lee (President, KGCF) 09:10 - 09:20 Welcoming Remarks Dr. Chung Sook Kim (Commissioner, KFDA) 09:20 - 09:30 Congratulatory Remarks I Dr. Sung Ro Chung (Chief Director, KSOG) PLENARY SESSION: Recent Progress in Researches on Papillomavirus Infection Chair: Prof. Jae-Wook Kim (Yonsei Univ. Colleage of Medicine) Prof. Kuy Wan Lee (Korea Univ.) 09:30 - 10:10 Plenary Talk (I) Papillomavirus and Diseases Dr. John T. Schiller (NCI, NIH, USA) 10:10 - 10:50 Plenary Talk (II) The role of HPV variants and hereditary factors in cervical cancer Prof. Yong Sang Song (SNU) 10:50 - 11:10 Coffee break SESSION I. Current Status of Papillomavirus Drug Development Chair: Dr. Won Shin (KFDA, Korea) Prof. Kyung Tai Kim (Hanyang Univ.) 11:10 - 11:40 Papillomavirus and Therapeutics including Therapeutic Vaccine Dr. Thomas Jonathan Chambers (MSD, USA) 11:40 - 12:10 Papillomavirus and Preventive Vaccine for Cancer Dr. Haryoung Poo (KRIBB, Korea) 12:10 - 12:40 Considerations and validation of HCII HPV DNA for Cervical Cancer Screening. Mr. Mark Van Asten (Digene Inc., Austrailia) 12:40 - 14:00 Lunch SESSION II. International Practice Trends on Clinical utility of HPV DNA Test in Clinical Management Chair: Dr. Yeowon Sohn (KFDA, Korea) Prof. Joo-Hyun Nam (Ulsan Univ.) 14:00 - 14:30 Australian Case Study Prof. Suzanne Garland (AUS) 14:30 - 15:00 China Case Study Prof. You-Lin Qiao (China) 15:00 - 15:30 Korean Case Study Prof. Jong Sup Park (Korea) 15:30 - 15:50 Coffee break SESSION III. Innovative Strategy of National Regulatory Authorities Chair: Dr. Sook Jin Hur (KFDA, Korea) Prof. Ho Suk Suh (Korea Univ.) 15:50 - 16:20 Accreditation of WHO Global Laboratory Network and WHO international refernce reagents Dr. Sue Nie Park (KFDA, Korea) 16:20 - 16:50 Establishment of Korean National References and Papillomavirus Genome Resource Bank Prof. Joo Sung Yang (SungKyunGwan Univ., Korea) 16:50 - 17:20 Establishment of Neutralizing Antibody Assay Methodology for Standardizing Efficacy Tests and Current Status of Establishing HPV VLP references Prof. Hong Jin Kim (ChoongAng Univ., Korea) 17:20 - 17:30 Q & A (Discussion) Concluding Remarks 17:30 - 17:40 Remarks by Director General, DBE Dr. Hong Ki Min (KFDA) 17:50 - 21:00 Reception Sep.. 5, 2005 (Monday) Satellite Meeting with Pharmaceutical Companies International Meeting Room (DBE Building), KFDA, Seoul, Korea Program SESSION (09:30-11:30) Chair : Dr. Seung Hwa Hong (KFDA, Korea) Vision on Papillomavirus Drug Production and Development : Chance and Risk for Vaccine and other drugs Dr. John T. Schiller (09:30-10:00) (NCI, NIH, USA) Dr. Thomas Jonathan Chambers (10:00-10:30) (MSD) Panelists : Dr. Suzanne Garland Dr. You-Lin, Qiao Dr. Jung Jin Lee (LG-LS, Korea) Dr. (SK chemical, Korea) Dr. (GreenCross, Korea)? Dr. Luis Jordar(IVI?) 12:00 - 13:30 Lunch